EDErnesto Deloya-Tomas

Ernesto Deloya-Tomas

*This is an algorithmically generated author record based on publicly available information.

Ernesto Deloya-Tomas has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reacción de hipersensibilidad inmediata aguda durante la terapia con antiveneno F(ab’)2 por envenenamiento grado II por serpiente de cascabel: reporte de caso en México

    by Georgina Flores Martini, Juan Carlos Borrego Moreno, Ana Elizabeth de la Cruz Reyes, Blanca Idalia Cardiel Méndez, Ernesto Deloya Tómas, Elizabeth Guadalupe Haro Cruz, Maria Julieta Cárdenas de Luna

    Rattlesnake envenomation remains a relevant cause of morbidity in Mexico, and antivenom is still the specific treatment of choice. We report the case of a 35-year-old man with grade II rattlesnake envenomation affecting the left hand, initially managed with six vials of equine polyvalent F(ab’)2 antivenom, analgesia, local supportive care, and serial clinical and laboratory monitoring. Approximately 30 minutes after antivenom administration, he developed fever, generalized pruritus, urticaria, and mild dyspnea, without hypotension, active bleeding, neurologic deterioration, or objective evidence of systemic venom progression. The event was interpreted as an acute immediate hypersensitivity reaction related to antivenom therapy. Symptom-directed treatment with antihistamines and corticosteroids was given, and antivenom was temporarily withheld for 24 hours. Because local edema persisted, antivenom was reintroduced under close monitoring and was well tolerated. The patient was readmitted one week later because of persistent edema, received additional antivenom according to clinical judgment, and showed favorable progression. This case highlights the importance of distinguishing venom progression from treatment-related hypersensitivity to support safe continuation of specific therapy when still clinically indicated.

  • Open Access

    Management of refractory status asthmaticus with sevoflurane in the intensive care unit: Case reports

    by Orlando Rubén Pérez-Nieto, Jorge Beauregard-Mora, Jonathan Reyes-Montufar, Carlos Mendiola-Villalobos, Alejandra Vargas-Torres, Diego Edgar Ledesma-López, Raúl Arturo González-Toribio, Alexis Stephano Henales-Ocampo, Tania Olga Mondragón-Labelle, Ernesto Deloya-Tomas

  • Open Access

    Management of Status Asthmaticus with Sevoflurane in the ICU: case report

    by Alexis Stephano Henales Ocampo, Orlando Rubén Pérez Nieto, Carlos Mendiola-Villalobos, Raúl Arturo González Toribio, Tania Olga Mondragon Labelle, Erenesto Deloya Tomas

    This case report describes a 66-year-old female patient with a 20-year history of asthma and type 2 diabetes mellitus, who was admitted for scheduled extracapsular cataract extraction. During recovery, she developed status asthmaticus, characterized by severe dyspnea, hypoxemia, and increased respiratory effort. Initial management included bronchodilators, systemic corticosteroids, and ketamine, but the patient remained unresponsive. The introduction of sevoflurane provided significant bronchodilatory effects, contributing to stabilization and early extubation. This case underscores the importance of timely interventions and the potential role of sevoflurane in managing refractory asthma exacerbations.

  • Open Access

    The Two-Gasometry Indirect Fick Method: An Inconsistent Method for Measuring Cardiac Output in Critical Patients

    by Daniela Cuellar-Mendoza, Javier Mancilla-Galindo, Esmeralda Garza-Santiago, Liliana Aline Fernandez-Urrutia, Gabriela Alejandra Bautista-Aguilar, Ashuin Kammar-García, Ernesto Deloya-Tomas, Orlando Ruben Perez-Nieto

    Background: The two-gasometry indirect Fick method (iFM) is commonly applied to estimate cardiac output (CO) and cardiac index (CI) in low-resource settings. Validation against other accessible methods such as transthoracic echocardiography (TTE) is lacking. Objective: To determine agreement and clinical interchangeability of CO and CI measurements from TTE (reference test) and two-gasometry iFM (index test) in critical care patients from a low-resource hospital. Methods: Cross-sectional study including critical patients. CO and CI were measured by intensive care medicine residents with TTE (3 per patient-event) and the two-gasometry iFM (1 per patient-event). Agreement was evaluated using mean absolute difference, linear mixed-effects models, and Bland-Altman analysis for repeated measures with 95% limits of agreement (LoA). Precision, bias, and variability were quantified with coefficients of variation, error, and least significant change (LSC), with 95% confidence intervals (95%CI) using bootstrapping. Results: A total 243 measurements were performed across 81 time points in 52 participants. Bland-Altman analysis and linear mixed-effects models revealed poor correlation for both CO (ICC = 0.09) and CI (ICC = -0.09). The mean bias between TTE and iFM was -1.59 L/min (95 LoA: -8.1 to 4.92) for CO and -1 L/min/m2 (95% LoA: -4.8 to 2.8) for CI. The mean absolute percentage error of the two-gasometry iFM method compared to TTE was 57.5% (95%CI: 45.5 to 74.6). The LSC was 11.9% for TTE and 80.4% for two-gasometry iFM. Conclusions: The two-gasometry indirect Fick method performs poorly compared to TTE and should not be used for decision making in critical patients.

  • Considerations and Concerns Regarding the Use of Ertapenem in Patients With Hypoalbuminemia: Is It Truly Inappropriate?

    by Marian Elizabeth Phinder-Puente, Orlando Rubén Pérez-Nieto, Tania Olga Mondragón-Labelle, Edgar Pérez-Barragán, Leonardo Soto Muñoz, Ernesto Deloya-Tomas

    Marian Elizabeth Phinder-Puente, Orlando Rubén Pérez-Nieto, Tania Olga Mondragón-Labelle, Edgar Pérez-Barragán, Leonardo Soto Muñoz, Ernesto Deloya-Tomas; Consi


  • Reply to Is the White Coat the Problem? Nurses’ Perspective

    by Héctor David Meza-Comparán, Javier Mancilla-Galindo, Ashuin Kammar-García, Marian E. Phinder-Puente, Saúl Rayo-Rodríguez, Ernesto Deloya-Tomas, Orlando R. Pérez-Nieto

  • Open Access

    Aplicaciones clínicas de la ecuación del movimiento del sistema respiratorio para la toma de decisiones en el paciente bajo ventilación mecánica invasiva: artículo de reflexión

    by Orlando Rubén Pérez-Nieto, Javier Mancilla-Galindo, Carlos Mendiola-Villalobos, Jorge Daniel Carrión-Moya, Eder Iván Zamarrón-López, Manuel Alberto Guerrero-Gutiérrez, Ernesto Deloya-Tomás, Jesús Salvador Sánchez-Díaz, Diego Escarraman-Martinez, Adolfo Israel Vásquez-Cuéllar, et al.

    Introducción: la ventilación mecánica es una práctica común en las unidades de cuidados intensivos y anestesiología. Tiene implicaciones terapéuticas, pero también es potencialmente nociva para el sistema respiratorio y los órganos distantes, por lo cual es imprescindible monitorizar los parámetros ventilatorios de manera continua. Objetivo: describir la ecuación del movimiento del sistema respiratorio y sus aplicaciones clínicas en el paciente bajo ventilación mecánica. Desarrollo: la ecuación del movimiento del sistema respiratorio integra las fuerzas dinámicas generadas por el ventilador y las propiedades intrínsecas del pulmón y la caja torácica. Expresa la presión en el sistema respiratorio en relación con el volumen, la elastancia, la resistencia, el flujo de aire y las presiones generadas por el ventilador y el paciente. Las presiones elevadas en el sistema respiratorio se asocian a una mayor mortalidad en pacientes con ventilación mecánica, por lo que la identificación de los componentes que condicionan la elevación de las presiones mediante la ecuación del movimiento del sistema respiratorio permite realizar modificaciones a los parámetros programados del ventilador para mantener una ventilación protectora. Conclusión: la toma de decisiones basada en la ecuación del movimiento del sistema respiratorio permite realizar ajustes en los parámetros ventilatorios según las características y enfermedades del paciente bajo ventilación mecánica.


  • Open Access

    Advantages and limitations of the ROX index

    by A. Gallardo, E. Zamarrón-López, E. Deloya-Tomas, O.R. Pérez-Nieto


  • Open Access

    Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX study

    by Orlando R. Perez-Nieto, Diego Escarraman-Martinez, Manuel A. Guerrero-Gutierrez, Eder I. Zamarron-Lopez, Javier Mancilla-Galindo, Ashuin Kammar-García, Miguel A. Martinez-Camacho, Ernesto Deloya-Tomás, Jesús S. Sanchez-Díaz, Luis A. Macías-García, et al.

    Background: The awake prone positioning strategy for patients with acute respiratory distress syndrome is a safe, simple and cost-effective technique used to improve hypoxaemia. We aimed to evaluate intubation and mortality risk in patients with coronavirus disease 2019 (COVID-19) who underwent awake prone positioning during hospitalisation.Methods: In this retrospective, multicentre observational study conducted between 1 May 2020 and 12 June 2020 in 27 hospitals in Mexico and Ecuador, nonintubated patients with COVID-19 managed with awake prone or awake supine positioning were included to evaluate intubation and mortality risk through logistic regression models; multivariable and centre adjustment, propensity score analyses, and E-values were calculated to limit confounding.Results: 827 nonintubated patients with COVID-19 in the awake prone (n=505) and awake supine (n=322) groups were included for analysis. Fewer patients in the awake prone group required endotracheal intubation (23.6%versus40.4%) or died (19.8%versus37.3%). Awake prone positioning was a protective factor for intubation even after multivariable adjustment (OR 0.35, 95% CI 0.24–0.52; pPaO2/FIO2) and management with a nonrebreather mask.Conclusions: Awake prone positioning in hospitalised nonintubated patients with COVID-19 is associated with a lower risk of intubation and mortality.